GE HealthCare Technologies Inc. Common Stock vs Standard Lithium Ltd — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Standard Lithium Ltd trades at $1.35 (market cap $345.40M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 89.5× Standard Lithium Ltd's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Standard Lithium Ltd pays none. Which is the better fit depends on your goals.
| GEHC | SLI | |
|---|---|---|
Market Cap | $30.93B | $345.40M |
Volume | 5,033,451 | 2,580,587 |
Sector | Health | Basic Materials |
52-Week High | $88.16 | $5.65 |
52-Week Low | $59.48 | $1.38 |
Enterprise Value | $39.39B | $208.31M |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 24 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Standard Lithium (SLI) trades at $1.43, down 4.03% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported no revenue in 2025, a net loss of $48.40 million, and negative cash flow from operations, though it secured significant financing. Key developments include progress toward a final investment decision for its Arkansas lithium project in 2026 and new offtake agreements, signaling potential future revenue streams.
The investment outlook is speculative, hinging on successful project execution and future lithium production. While analyst consensus is strongly bullish with a $3.83 price target, high execution risk and current lack of revenue present significant challenges. The stock offers high-risk, high-reward potential for investors betting on the company's transition to a lithium producer.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →